BA
Bristlecone Advisors’s Athira Pharma ATHA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-252,200
| Closed | -$71.9K | – | 296 |
|
|
2025
Q1 | $71.9K | Sell |
252,200
-85,306
| -25% | -$24.3K | 0.01% | 306 |
|
|
2024
Q4 | $198K | Hold |
337,506
| – | – | 0.02% | 275 |
|
|
2024
Q3 | $151K | Buy |
337,506
+252,200
| +296% | +$112K | 0.01% | 286 |
|
|
2024
Q2 | $226K | Hold |
85,306
| – | – | 0.02% | 259 |
|
|
2024
Q1 | $234K | Hold |
85,306
| – | – | 0.02% | 259 |
|
|
2023
Q4 | $207K | Hold |
85,306
| – | – | 0.02% | 262 |
|
|
2023
Q3 | $172K | Hold |
85,306
| – | – | 0.02% | 258 |
|
|
2023
Q2 | $252K | Hold |
85,306
| – | – | 0.03% | 238 |
|
|
2023
Q1 | $213K | Sell |
85,306
-611,323
| -88% | -$1.53M | 0.02% | 254 |
|
|
2022
Q4 | $2.21M | Sell |
696,629
-4,297
| -0.6% | -$13.6K | 0.27% | 80 |
|
|
2022
Q3 | $2.08M | Hold |
700,926
| – | – | 0.27% | 76 |
|
|
2022
Q2 | $2.14M | Sell |
700,926
-60,637
| -8% | -$185K | 0.26% | 81 |
|
|
2022
Q1 | $10.3M | Hold |
761,563
| – | – | 1.26% | 21 |
|
|
2021
Q4 | $9.92M | Hold |
761,563
| – | – | 1.19% | 18 |
|
|
2021
Q3 | $7.14M | Hold |
761,563
| – | – | 0.93% | 22 |
|
|
2021
Q2 | $7.8M | Buy |
+761,563
| New | +$7.8M | 1.06% | 22 |
|